- Hemoshear drug hunting prowess 'REVEALed' in potential $470M+ Takeda liver disease deal
- Gene-eye out of the bottle: 'Precision' approach draws $42.5M series A for Gemini
- Hearing offers little 'HELP' in reining in U.S. drug prices
- EMA casts a cold eye on Brexit disruption
- Immune Design gets FDA blessing, goes pivotal with CMB-305 in synovial sarcoma
The volume of biopharmaceutical deals have steadily declined each quarter this year, with only 200 recorded in the third quarter, a 23 percent fall over the second-quarter deal total and a 28 percent drop over the first-quarter number. However, in terms of value, third-quarter deals represented a total value of $21.7 billion, in line with the first quarter, and double that generated in the second quarter. (See Biopharma Deals: 2017, page 2.)
One of the challenges for weight loss is that the body is evolutionarily programmed to worry about famines, not feasts. As a result, losing weight, if not exactly easy, is achievable for many individuals. Keeping that weight off, though, is a formidable challenge, because weight loss sets off powerful compensatory mechanisms in the body. (See BioWorld, Sept. 26, 2017.)
READ MORE »- CAR T-cell therapy goes back to its HIV roots »
- 'Brutal test' shows partial protein can reverse Rett syndrome »
- Synthetic antibody-based GPCR endocytosis inhibitor developed, study shows »
- Crystal-clear images, no crystal required »
- Stem cell-derived EPO-producing cells can ameliorate renal anemia »
- New method maps long-range gene regulation »
- Approach may prevent hair loss from cancer therapy »
- Gene therapy helps formerly rotund rodents keep off the weight »
- Carbohydrates may hold key to improved malaria vaccine »
- Drug quality from a patient’s perspectiveSeptember 10, 2017 | 2:06 PM | Posted by: Mari Serebrov
- Importation a cliché, not a CAPAAugust 04, 2017 | 11:08 PM | Posted by: Mari Serebrov
- Life and death and #BIO2017June 26, 2017 | 10:18 PM | Posted by: Marie Powers
- No choice, no free marketJune 20, 2017 | 6:35 PM | Posted by: Mari Serebrov
- Poverty, politics and preventable disease: Blurring the lines between truth and fiction in BioWorld’s 11th annual Summer Reading ListJune 01, 2017 | 4:13 PM | Posted by: Marie Powers
Partners in Focus
